Frequently Asked Questions
The market is segmented based on Global N-Acetylglutamate Synthase Deficiency Market, By Diagnosis (Genetic Testing, New-born Screening Others), Treatment (Medications, Alternative Treatment, Others), Drug Type (Branded, Generic), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others) – Industry Trends and Forecast to 2030.
.
The Global N Acetylglutamate Synthase Deficiency Market size was valued at USD 1.30 USD Billion in 2022.
The Global N Acetylglutamate Synthase Deficiency Market is projected to grow at a CAGR of 3.5% during the forecast period of 2023 to 2030.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
